FDA NDC Directory · JSON-LD · Markdown

Lenalidomide

NDC 60505-4532 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA211022
Dosage form / routeCAPSULE · ORAL
Active ingredientsLENALIDOMIDE (2.5 mg/1)
Marketing started20230309
Package count1

External sources

Source: openFDA. Public-domain (CC0).